Claudia Ordonez, Chief Medical Officer at Keros Therapeutics, Inc. (KROS), sold 1,000 shares at $50.15 ($50K) on 2021-05-11, disclosed to the SEC on 2021-05-13.
Open-market sale of $50k KROS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KROS | SELL | 2021-03-15 | $65K | — | Filing → |
| KROS | SELL | 2021-02-16 | $65K | — | Filing → |